Business Context and Reporting Period
Company: ProMIS Neurosciences Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 13, 2023
Event: Material Modification to Rights of Security Holders (Continuance)
On July 13, 2023, ProMIS Neurosciences Inc. completed its continuance from a corporation incorporated under the Canada Business Corporations Act (CBCA) to the Province of Ontario under the Business Corporations Act (Ontario) (OBCA). This action was approved by shareholders at the 2023 Annual Meeting on June 29, 2023. The continuance did not create a new legal entity, nor did it alter the Company's business, management, assets, liabilities, or net worth.
Financial Metrics
This filing is a current report regarding a corporate governance event and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing explicitly states that the continuance did not result in any change to the Company's assets, liabilities, or net worth.
Material Changes Versus Prior Period
The primary material change is the shift in the Company's legal domicile and governing statute from federal (CBCA) to provincial (OBCA). While the Company's operations and financial position remain unchanged, specific shareholder rights and corporate governance provisions have been modified to align with the OBCA. Key differences include:
- Director Residency: The OBCA removes the requirement for directors to be resident Canadians, whereas the CBCA required at least one-quarter of directors to be resident Canadians.
- Independent Directors: The OBCA requires at least one-third of the board to be independent (not officers or employees), whereas the CBCA required at least two directors to be independent.
- Oppression Remedy: The OBCA allows courts to grant relief where a prejudicial effect is merely threatened, while the CBCA requires the effect to actually exist.
- Short Selling: The CBCA prohibits insiders from short selling unless they own the securities; the OBCA does not contain this prohibition.
- Shareholder Proposals: Both statutes allow proposals, but the OBCA explicitly permits submission by beneficial shareholders without the specific ownership duration/value thresholds required under the CBCA for certain proposal discussions.
Guidance, Outlook, and Risks
Management Commentary: Management states that the provisions of the OBCA dealing with shareholder rights and protections are generally comparable to the CBCA, and shareholders will not lose or gain any significant rights or protections as a result of the continuance.
Risks and Contingencies:
- Constitutional Jurisdiction: Unlike CBCA corporations which have the right to carry on business throughout Canada, OBCA companies must register to do business in other provinces and may be subject to provincial restrictions on their ability to operate or use their corporate name.
- Legal Continuity: The Company remains subject to all liabilities, contracts, and legal actions as if it had been incorporated under the OBCA from the start.
Unusual Items: None reported. The filing confirms no change in headquarters, jobs, or material contracts.
Key Facts for Investor Verification
- Verify the Company's new legal domicile is the Province of Ontario under the OBCA.
- Confirm that the Company's listing status on the Toronto Stock Exchange and Nasdaq remains unchanged.
- Review the new Articles of Continuance and Amended By-laws (Exhibits 3.1, 3.2, 3.3) for specific governance changes.
- Note the removal of Canadian residency requirements for directors, which may impact board composition.
- Understand that while the legal framework changed, the Company's financial obligations and material contracts remain intact.